--- title: When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis description: "The introduction and adoption of artificial intelligence in systematic literature reviews: a discrete choice experiment." image: https://health-ecore.com/hubfs/AI-Generated%20Media/Images/review%20human-1.png --- [Skip to the main content.](https://health-ecore.com/news/when-ai-meets-systematic-reviews-and-shapes-the-future-of-evidence-synthesis#main-content) [![HE\_logo\_fc-35-1](https://health-ecore.com/hs-fs/hubfs/HE_logo_fc-35-1.png?width=1500&height=326&name=HE_logo_fc-35-1.png "HE_logo_fc-35-1")](https://health-ecore.com/) [![Health-Ecore](https://health-ecore.com/hs-fs/hubfs/HE_logo_fc-35.png?width=1772&height=385&name=HE_logo_fc-35.png "Health-Ecore")](https://health-ecore.com/) - [Home](https://health-ecore.com) - [About us](https://health-ecore.com/about-us) - Our work - [Scientific work](https://health-ecore.com/publications) - [RSV web app](https://health-ecore.com/news/rsv-vaccination-a-cost-effective-strategy-for-older-adults-in-the-netherlands) - [DRAIGON SLR app](https://slrmadraigon.apps.health-ecore.com/) - [Team](https://health-ecore.com/team) - [News](https://health-ecore.com/news) - [Contact](https://health-ecore.com/contact) Toggle Menu Toggle Menu - [Home](https://health-ecore.com) - [About us](https://health-ecore.com/about-us) - Our work - [Scientific work](https://health-ecore.com/publications) - [RSV web app](https://health-ecore.com/news/rsv-vaccination-a-cost-effective-strategy-for-older-adults-in-the-netherlands) - [DRAIGON SLR app](https://slrmadraigon.apps.health-ecore.com/) - [Team](https://health-ecore.com/team) - [News](https://health-ecore.com/news) - [Contact](https://health-ecore.com/contact) [Linkedin](https://www.linkedin.com/company/health-ecore/posts/?feedView=all) 1 min read # When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis [![Picture of Tanja Fens](https://health-ecore.com/hs-fs/hubfs/Screenshot%202025-10-10%20at%2015.26.13.png?width=30&height=30&name=Screenshot%202025-10-10%20at%2015.26.13.png) Tanja Fens](https://health-ecore.com/news/author/tanja-fens) : Published October 17, 2025 Updated November 4, 2025 [discrete choice experiment (DCE)](https://health-ecore.com/news/tag/discrete-choice-experiment-dce) [Systematic literature reviews (SLRs)](https://health-ecore.com/news/tag/systematic-literature-reviews-slrs) [Artificial Intelligence (AI)](https://health-ecore.com/news/tag/artificial-intelligence-ai) ![When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis](https://health-ecore.com/hs-fs/hubfs/AI-Generated%20Media/Images/review%20human-1.png?width=1024&height=537&name=review%20human-1.png) Imagine a researcher at their desk, surrounded by hundreds of open articles, spreadsheets filled with study data, and the constant ticking of deadlines. Systematic literature reviews (SLRs) are essential for understanding the state of scientific evidence, yet the process can feel like wading through an endless sea of studies. Every title must be screened, every abstract evaluated, and every finding carefully extracted. It is meticulous, exhausting work—and for many, the sheer volume can feel overwhelming. *Systematic reviews are the backbone of evidence-based research—but conducting them can feel like an uphill battle against time and data.* Amid this challenge, artificial intelligence (AI) offers a tantalizing promise: tools that can help screen studies faster, reduce repetitive workload, and assist researchers without replacing their expertise. But how do researchers actually perceive AI in this context, and what drives their willingness to adopt it? ## Exploring Researchers’ Preferences A recent study "The introduction and adoption of artificial intelligence in systematic literature reviews: a discrete choice experiment" tackled this question through a discrete choice experiment involving 187 participants with diverse experience in SLRs and varying familiarity with AI. Participants were presented with hypothetical AI tools that differed in key characteristics, including the role of the AI in screening, the sensitivity of its outputs, the level of user proficiency required, and the effort needed for training. The aim was to understand the trade-offs researchers make when deciding whether to adopt AI tools in their work. ![The future of AI in research synthesis lies not in replacing human reviewers but in partnering with them to make the process more efficient and reliable-1-1](https://health-ecore.com/hs-fs/hubfs/AI-Generated%20Media/Images/The%20future%20of%20AI%20in%20research%20synthesis%20lies%20not%20in%20replacing%20human%20reviewers%20but%20in%20partnering%20with%20them%20to%20make%20the%20process%20more%20efficient%20and%20reliable-1-1.png?width=1024&height=707&name=The%20future%20of%20AI%20in%20research%20synthesis%20lies%20not%20in%20replacing%20human%20reviewers%20but%20in%20partnering%20with%20them%20to%20make%20the%20process%20more%20efficient%20and%20reliable-1-1.png) ## Insights from the Study The findings revealed a nuanced landscape. Workload reduction emerged as an important motivator, but it was not the only consideration. Researchers preferred tools that complemented human judgment rather than replaced it. Tools requiring moderate proficiency were more likely to be adopted, while AI solutions demanding expert-level skills sometimes discouraged even highly experienced scientists. Interestingly, researchers with extensive experience in conducting SLRs were more open to adopting AI, whereas those with broader scientific expertise tended to hesitate if the tools seemed too complex.   ## Implications for the Future The study highlights a clear path for AI in systematic reviews: tools must be reliable, sensitive, and supportive, reducing effort without compromising judgment. When designed thoughtfully, AI can transform SLRs from a daunting, resource-heavy process into a more manageable, efficient workflow—allowing researchers to focus on analysis, insights, and decision-making rather than repetitive screening. This research was conducted by **Seye Abogunrin, Bart P H Slob, Marie Lane, Sajad Emamipour, Piotr Twardowski, Cornelis Boersma, and Jurjen van der Schans**, offering valuable guidance for developers and research teams working to integrate AI into evidence synthesis. [READ THE RESEARCH ARTICLE HERE](https://bmjopen.bmj.com/content/15/10/e099921.full)   [![High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands](https://health-ecore.com/hubfs/AI-Generated%20Media/Images/Ealdery%20Vaccination%20with%20High%20Dose%20Influenza%20Shot-1-1.png)](https://health-ecore.com/news/high-dose-influenza-vaccination-remains-a-cost-effective-investment-for-older-adults-in-the-netherlands) #### [High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands](https://health-ecore.com/news/high-dose-influenza-vaccination-remains-a-cost-effective-investment-for-older-adults-in-the-netherlands) [![Picture of Tanja Fens](https://health-ecore.com/hs-fs/hubfs/Screenshot%202025-10-10%20at%2015.26.13.png?width=30&name=Screenshot%202025-10-10%20at%2015.26.13.png) Tanja Fens](https://health-ecore.com/news/author/tanja-fens) : 24 June 2026, 14:12:34 CEST The introduction and adoption of artificial intelligence in systematic literature reviews: a discrete choice experiment. [Vaccination](https://health-ecore.com/news/tag/vaccination) [Influenza](https://health-ecore.com/news/tag/influenza) [Cost-effectiveness analysis](https://health-ecore.com/news/tag/cost-effectiveness-analysis) [Read More](https://health-ecore.com/news/high-dose-influenza-vaccination-remains-a-cost-effective-investment-for-older-adults-in-the-netherlands) [![Next-generation COVID-19 vaccine mRNA-1283 is a cost-effective investment for older and high-risk adults in the Netherlands](https://health-ecore.com/hubfs/AI-Generated%20Media/Images/NextGen%20Vaccine%20Impact%20in%20Netherlands-2-1.png)](https://health-ecore.com/news/next-generation-covid-19-vaccine-mrna-1283-is-a-cost-effective-investment-for-older-and-high-risk-adults-in-the-netherlands) #### [Next-generation COVID-19 vaccine mRNA-1283 is a cost-effective investment for older and high-risk adults in the Netherlands](https://health-ecore.com/news/next-generation-covid-19-vaccine-mrna-1283-is-a-cost-effective-investment-for-older-and-high-risk-adults-in-the-netherlands) [![Picture of Simon van der Pol](https://app.hubspot.com/settings/avatar/6076bb0cafb0b64e016c0b629cc901de) Simon van der Pol](https://health-ecore.com/news/author/simon-van-der-pol) : 21 September 2026, 16:27:08 CEST The introduction and adoption of artificial intelligence in systematic literature reviews: a discrete choice experiment. [Vaccination](https://health-ecore.com/news/tag/vaccination) [COVID-19](https://health-ecore.com/news/tag/covid-19) [Cost-effectiveness analysis](https://health-ecore.com/news/tag/cost-effectiveness-analysis) [Read More](https://health-ecore.com/news/next-generation-covid-19-vaccine-mrna-1283-is-a-cost-effective-investment-for-older-and-high-risk-adults-in-the-netherlands) [![Health-Ecore and Pharma & Health Policy Hub Announce Strategic Partnership](https://health-ecore.com/hubfs/antoine-schibler-KF3Ty-K6NVA-unsplash.jpeg)](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) #### [Health-Ecore and Pharma & Health Policy Hub Announce Strategic Partnership](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) [![Picture of Tanja Fens](https://health-ecore.com/hs-fs/hubfs/Screenshot%202025-10-10%20at%2015.26.13.png?width=30&name=Screenshot%202025-10-10%20at%2015.26.13.png) Tanja Fens](https://health-ecore.com/news/author/tanja-fens) : 10 October 2025, 15:28:23 CEST Health-Ecore and the Pharma & Health Policy Hub have entered into a strategic partnership to advance research, provide expert advisory services, and... [Partnership](https://health-ecore.com/news/tag/partnership) [Collaboration](https://health-ecore.com/news/tag/collaboration) [Health Policy](https://health-ecore.com/news/tag/health-policy) [Sustainable Healthcare](https://health-ecore.com/news/tag/sustainable-healthcare) [Read More](https://health-ecore.com/news/health-ecore-and-pharma-health-policy-hub-announce-partnership-to-drive-sustainable-impact-in-healthcare) [![The broader societal impact of Alzheimer's disease in the Netherlands](https://health-ecore.com/hubfs/robina-weermeijer-IHfOpAzzjHM-unsplash-1-1.jpeg)](https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease) #### [The broader societal impact of Alzheimer's disease in the Netherlands](https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease) [![Picture of Simon van der Schans](https://app.hubspot.com/settings/avatar/9be45cf1daa01220a3267c98d955a2b7) Simon van der Schans](https://health-ecore.com/news/author/simon-van-der-schans) : 18 September 2025, 14:57:30 CEST Discover the societal impact of Alzheimer’s in the Netherlands and how new treatments can reduce care needs and costs while improving patient... [Alzheimer's Disease](https://health-ecore.com/news/tag/alzheimers-disease) [Societal Cost-Benefit Analysis](https://health-ecore.com/news/tag/societal-cost-benefit-analysis) [Care Capacity](https://health-ecore.com/news/tag/care-capacity) [Read More](https://health-ecore.com/news/the-broader-societal-impact-of-alzheimers-disease) ![HE\_Invest\_Innovate\_Implement-39](https://health-ecore.com/hs-fs/hubfs/HE_Invest_Innovate_Implement-39.png?width=500&height=36&name=HE_Invest_Innovate_Implement-39.png)   - [Contact details](https://health-ecore.com/contact) - [Privacy policy](https://health-ecore.com/privacy-policy) - [LinkedIn policy](https://health-ecore.com/linkedin-rules) © 2026 Health-Ecore B.V. [Linkedin](https://www.linkedin.com/company/health-ecore/posts/?feedView=all) [GitHub](https://github.com/Health-Ecore) Chamber of Commerce: 72059419 | Tax registration: NL 858968447 B01 Return to top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Tanja Fens", "url" : "https://health-ecore.com/news/author/tanja-fens" }, "dateModified" : "2025-11-04T21:30:15.536Z", "datePublished" : "2025-10-17T15:56:04.000Z", "headline" : "When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis", "image" : [ "https://health-ecore.com/hubfs/AI-Generated%20Media/Images/review%20human-1.png" ], "mainEntityOfPage" : { "@id" : "https://health-ecore.com/news/when-ai-meets-systematic-reviews-and-shapes-the-future-of-evidence-synthesis", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://health-ecore.com/hubfs/HE_logo_fc-35.png" }, "name" : "Health-Ecore B.V." } } ``` ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : [ { "@type" : "Person", "name" : "Tanja Fens", "url" : "https://health-ecore.com/news/author/tanja-fens" } ], "dateModified" : "2025-11-04T21:30:15Z", "datePublished" : "2025-10-17T15:56:04Z", "description" : "The introduction and adoption of artificial intelligence in systematic literature reviews: a discrete choice experiment. ", "headline" : "When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis", "image" : [ "https://26748615.fs1.hubspotusercontent-eu1.net/hubfs/26748615/AI-Generated%20Media/Images/review%20human-1.png" ], "inLanguage" : "en", "keywords" : "discrete choice experiment (DCE), Systematic literature reviews (SLRs), Artificial Intelligence (AI)", "mainEntityOfPage" : { "@id" : "https://health-ecore.com/news/when-ai-meets-systematic-reviews-and-shapes-the-future-of-evidence-synthesis", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "name" : "Health-Ecore B.V." } } ```